scispace - formally typeset
C

Charles H. Cook

Researcher at Beth Israel Deaconess Medical Center

Publications -  166
Citations -  5210

Charles H. Cook is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Intensive care unit & Congenital cytomegalovirus infection. The author has an hindex of 38, co-authored 165 publications receiving 4531 citations. Previous affiliations of Charles H. Cook include Brigham and Women's Hospital & Ohio State University.

Papers
More filters
Journal ArticleDOI

Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection

TL;DR: In patients with intraabdominal infections who had undergone an adequate source-control procedure, the outcomes after fixed-duration antibiotic therapy were similar to those after a longer course of antibiotics that extended until after the resolution of physiological abnormalities.
Journal ArticleDOI

Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function.

TL;DR: This work establishes the first chronic preclinical model of wound biofilm infection aimed at addressing the long‐term host response and leads to the notion that even if a biofilm infected wound is closed, it may be complicated by the presence of failed skin, which is likely to be infected and/or further complicated postclosure.
Journal ArticleDOI

Pain and wound healing in surgical patients.

TL;DR: These findings extend the previous laboratory models of wound healing to a surgical population, providing the first evidence that pain plays an important role in postsurgery wound healing, a key variable in postsurgical recovery.
Journal ArticleDOI

Complications associated with pulmonary artery catheters: a comprehensive clinical review.

TL;DR: This review categorizes complications associated with the Pulmonary artery catheters into four broad groups — Complications of central venous access; complications related to PAC insertion and manipulation; complicationsassociated with short- or long-term presence of the PAC in the cardiovascular system; and errors resulting from incorrect interpretation/use of PAC-derived data.
Journal ArticleDOI

Designing isoform-specific peptide disruptors of protein kinase A localization

TL;DR: To evaluate the effects of each localized isoform, peptides that specifically bind to either RI or RII are designed that will be invaluable tools to evaluate functional differences between localized RI and RII PKA and are RIα-specific disruptors.